Back to Royal Bank of Canada Royal Bank of Canada

AUPHAUPH

Showing 8 of 28 quarters

Position history for Royal Bank of CanadaRoyal Bank of Canada's holdings in Aurinia Pharmaceuticals Inc

Yes. Royal Bank of Canada holds 16,135 shares of AUPH (Aurinia Pharmaceuticals), worth $273,000, as of its Q2 2026 13F filing. It increased the position by 5,158 shares (+47.0%) from Q1 2026. Royal Bank of Canada has held AUPH in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$273,000

Current Shares

16,135

Total Value Change

-$138,000

Total Shares Change

-39,972

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
16,135
+47.0%
$273,0000.0%$16.97
22
2026-Q1
Decreased
10,977
-27.3%
$163,0000.0%$14.82
0
2025-Q4
Decreased
15,093
-94.5%
$240,0000.0%$15.95
0
2025-Q3
Decreased
276,320
-1.5%
$3.1M0.0%$11.05
0
2025-Q2
Decreased
280,518
-23.7%
$2.4M0.0%$8.47
0
2025-Q1
Increased
367,661
+65.3%
$3M0.0%$8.04
39
2024-Q4
Increased
222,482
+296.5%
$2M0.0%$8.98
42
2024-Q3
Increased
56,107
+32.7%
$411,0000.0%$7.28
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used